Cargando…

Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events

BACKGROUND: Neurological immune-related adverse events (irAE-n) are severe and potentially fatal toxicities of immune checkpoint inhibitors (ICI). To date, the clinical significance of neuronal autoantibodies in irAE-n is poorly understood. Here, we characterize neuronal autoantibody profiles in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller-Jensen, Leonie, Knauss, Samuel, Ginesta Roque, Lorena, Schinke, Christian, Maierhof, Smilla K., Bartels, Frederik, Finke, Carsten, Rentzsch, Kristin, Ulrich, Claas, Mohr, Raphael, Stenzel, Werner, Endres, Matthias, Boehmerle, Wolfgang, Huehnchen, Petra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945255/ https://www.ncbi.nlm.nih.gov/pubmed/36845122 http://dx.doi.org/10.3389/fimmu.2023.1108116

Ejemplares similares

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2022)

Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice
por: Huehnchen, Petra, et al.
Publicado: (2013)

Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2018)

Induced pluripotent stem cell-derived brain organoids as potential human model system for chemotherapy induced CNS toxicity
por: Scholz, Sophie, et al.
Publicado: (2022)

Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice
por: Huehnchen, Petra, et al.
Publicado: (2020)

Neuronal autoantibodies associated with cognitive impairment in melanoma patients
por: Bartels, F, et al.
Publicado: (2019)

Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice
por: Boehmerle, Wolfgang, et al.
Publicado: (2014)

A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
por: Huehnchen, P, et al.
Publicado: (2017)

Focal brain ischemia in mice does not cause electrophysiological signs of critical illness neuropathy
por: Huehnchen, Petra, et al.
Publicado: (2020)

Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons
por: Schinke, Christian, et al.
Publicado: (2021)

Anti-ARHGAP26 Autoantibodies Are Associated With Isolated Cognitive Impairment
por: Bartels, Frederik, et al.
Publicado: (2018)

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis
por: Müller-Jensen, Leonie, et al.
Publicado: (2022)

Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
por: von der Ahe, David, et al.
Publicado: (2018)

Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition
por: Huehnchen, Petra, et al.
Publicado: (2020)

Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
por: Ghosh, Nilasha, et al.
Publicado: (2022)

Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
por: Hansen, Niels, et al.
Publicado: (2023)

Dysfunctional Learning and Verbal Memory in Patients with Elevated Tau Protein Levels and Serum Recoverin Autoantibodies—Case Series and Review
por: Hansen, Niels, et al.
Publicado: (2021)

Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitors
por: Helderman, N.C., et al.
Publicado: (2023)

Management of the Adverse Effects of Immune Checkpoint Inhibitors
por: Morgado, Manuel, et al.
Publicado: (2020)

Case Report: Semantic Variant of Primary Progressive Aphasia Associated With Anti-Glial Fibrillary Acid Protein Autoantibodies
por: Hansen, Niels, et al.
Publicado: (2022)

Salinomycin induces calpain and cytochrome c-mediated neuronal cell death
por: Boehmerle, W, et al.
Publicado: (2011)

Long-Term Course of Neural Autoantibody-Associated Psychiatric Disorders: Retrospective Data from a Specifically Immunopsychiatric Outpatient Clinic
por: Hansen, Niels, et al.
Publicado: (2023)

Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
por: Kordelas, Lambros, et al.
Publicado: (2021)

Persisting Verbal Memory Encoding and Recall Deficiency after mGluR5 Autoantibody-Mediated Encephalitis
por: Hansen, Niels, et al.
Publicado: (2023)

Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events
por: Alserawan, Leticia, et al.
Publicado: (2022)

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
por: Daban, A, et al.
Publicado: (2023)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review
por: Hansen, Niels, et al.
Publicado: (2023)

Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
por: Farina, Antonio, et al.
Publicado: (2023)

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin
por: Qiu, Junlin, et al.
Publicado: (2022)

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
por: Johannet, Paul, et al.
Publicado: (2022)

PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited
por: Knauss, Samuel, et al.
Publicado: (2019)

Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study
por: Les, Iñigo, et al.
Publicado: (2022)

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors
por: Guidon, Amanda C, et al.
Publicado: (2021)

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial
por: Huehnchen, Petra, et al.
Publicado: (2022)

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis
por: Cabral-Marques, Otavio, et al.
Publicado: (2018)

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors
por: Wilson, Robert, et al.
Publicado: (2018)

Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
por: Albarrán, Víctor, et al.
Publicado: (2022)

Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
por: Duong, Sophie L., et al.
Publicado: (2022)

Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
por: Zaenker, Pauline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h47v4htj12sb1haj3fkngboda3